About Us

CIHAN AY, MD

Medical University of Vienna, Vienna, Austria

 

Cihan Ay, MD, is an associate professor at the Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria. He has been appointed as Director of the Haemophilia Center and co-Director of the Thrombosis program. Previously, he was a visiting research assistant professor at the University of North Carolina at Chapel Hill, NC, USA.

 

Dr Ay’s research interest concerns bleeding disorders, venous thromboembolism and anticoagulant therapy. He has been a principal investigator and study coordinator for several interventional and observational studies. He has been an author and coauthor of >150 articles on different topics in the field of haemostasis and thrombosis, and his work has been published in peer-reviewed journals such as Lancet Haematology, Journal of Clinical Oncology, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis Research, and many more.

 

Dr Ay is an associate editor for Research and Practice in Thrombosis and Haemostasis (RPTH) and Frontiers in Cardiovascular Medicine. He serves on the editorial board of the Journal of Thrombosis and Haemostasis, Thrombosis Research, Hämostaseologie, and as a reviewer for several journals.

 

Dr Ay is a member of the International Society on Thrombosis and Haemostasis (ISTH), German, Austrian and Swiss Society of Thrombosis and Hemostasis Research (GTH), European Hematology Association (EHA), Austrian Society of Hematology & Medical Oncology (OeGHO), Austrian Hemophilia Association (ÖHG) and the Austrian Society of Internal Medicine (ÖGIM).

 

ERIK BERNTORP, MD, PhD

Malmö Centre for Thrombosis and Haemostasis, Malmö, Sweden

 

Erik Berntorp studied at Lund University and completed his training at the University Hospital in Malmö, Sweden. He specialised in internal medicine, haematology and coagulation disorders. Since 1985, he has worked at the Malmö Centre for Thrombosis and Haemostasis, where he served as director for 20 years. He is a professor at Lund University in Sweden.

 

Professor Berntorp's research interests include prophylactic treatment of haemophilia and von Willebrand disease, genetic aspects on inhibitor development, and the treatment of inhibitors in haemophilia; including by-pass therapy and immune tolerance induction.

 

Professor Berntorp is the Principal Investigator for several multinational studies and is a reviewer of numerous scientific journals such as Blood, Journal of Thrombosis and Haemostasis and Haemophilia. He has published around 300 papers in peer-reviewed journals and has been the editor for a number of major textbooks including Textbook of Hemophilia and Von Willebrand Disease: Basic and Clinical Aspects.

 

Professor Berntorp has served on the councils of the World Federation of Hemophilia (WFH) and the European Hematology Association (EHA).

 

MANUELA CARVALHO, MD

São João Hospital Centre, Porto, Portugal

 

Manuela Carvalho is a consultant in haematology, immunology and haemotherapy at the Department of Transfusion Medicine and Blood Bank, Centre of Thrombosis and Haemostasis at São João University Hospital in Porto, Portugal. She is also Head of the Thrombosis, Haemostasis and Haemophilia Centre at São João Hospital Centre.

 

Since 1999, Dr Carvalho has been responsible for the treatment of children and adult patients with haemophilia and bleeding related disorders in Porto. Her research interests include the diagnosis and treatment of bleeding disorders, anticoagulation in thrombophilic conditions, and the prophylactic treatment of haemophilia and inhibitor issues.

 

Dr Carvalho is the Principal Investigator in clinical trials on bleeding related disorders and has authored/co-authored publications in the field of haemophilia, bleeding disorders, haemostasis and haemorrhage control in peer-reviewed journals such as Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology, and Haemophilia.

 

PIERRE FONTANA, MD, PhD

University Hospitals of Geneva, Switzerland

 

Pierre Fontana graduated from the Faculty of Medicine of Lausanne in 1994 and obtained a PhD in 2003 from the University Paris V. He is board certified in internal medicine and angiology and joined the Division of Angiology and Hemostasis at the University Hospitals of Geneva in 2002. He has been the Head of the Hemostasis Laboratory since 2009 and Head of the Hemostasis Unit since 2015. He is also the co-founder of the Geneva Platelet Group.

 

Professor Fontana specializes in hemorrhagic and thrombotic disorders and his research is mainly focused on platelets. He has authored more than 100 papers related to platelet function, management of patients at risk of bleeds, antithrombotic therapy and laboratory monitoring of anti-hemophiliac products.

 

VÍCTOR JIMÉNEZ-YUSTE, MD, PhD

La Paz University Hospital, Madrid, Spain

 

VÍctor Jiménez-Yuste is the Associate Professor of Haematology at the Autonomous University of Madrid in Spain, and Head of the Haematology Department at La Paz University Hospital in Madrid. After completing his medical degree at Valladolid University, he specialised in haematology at La Paz University Hospital. He was awarded his PhD by the Autonomous University of Madrid, where he completed his thesis studying haemophilia and HIV infection.

 

Dr Jiménez-Yuste is a member of the Executive Committee of the Spanish Society of Thrombosis and Haemostasis (SETH). His research interests include the management of inherited bleeding disorders, idiopathic thrombocytopenic purpura and acquired haemophilia. He has authored/co-authored more than 70 papers in various journals about these issues.

 

OLGA KATSAROU, MD, PhD

Laiko General Hospital of Athens, Athens, Greece

 

Olga Katsarou is Head of the Blood Transfusion Unit, National Reference Centre for Congenital Bleeding Disorders and Haemostasis Unit at "Laiko" General Hospital of Athens in Greece.

 

After Dr Katsarou obtained her medical degree at Athens University Medical School, she specialised in internal medicine. She undertook her doctoral thesis at Athens University on HIV/HCV infections in haemophilia patients.

 

Dr Katsarou previously worked as a medical doctor and researcher in the Department of Internal Medicine at Athens University. In 1991, she became a consultant at the 2^nd Blood Regional Transfusion Centre and Haemophilia Centre of Laiko General Hospital, where she worked with patients with hereditary and acquired bleeding disorders.

 

Dr Katsarou is the author of several publications in haemophilia and haemostasis. She has participated in many clinical trials as the Principal and a sub-investigator and she is a member of several multicentre studies and advisory boards. She is active in many regional, national and international committees and scientific societies and had chaired the Haemostasis Committee of the Hellenic Society of Haematology.

 

GILI KENET, MD

Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

 

Gili Kenet is a paediatric haematologist and the Professor of Haematology at the Tel Aviv University in Israel. She is Director of the Israeli National Hemophilia Center and Institute of Thrombosis and Hemostasis at the Sheba Medical Center in Tel Hashomer, and Head of Haematology at the Sackler Medical School at Tel Aviv University. She received her medical degree from the Hebrew University in Jerusalem, Israel.

 

Professor Kenet's research projects focus on neonatal haemostasis, childhood stroke and paediatric thrombophilia, as well as the clinical research of new therapy modes applied to people with haemophilia. She has been awarded national grants for paediatric haematology and cancer research, and recently for studying recombinant factor VIIa mode of action, tailoring bypass agents' therapy, and applying global haemostasis assays for patients with haemophilia and inhibitors.

 

Professor Kenet is the author of over 150 manuscripts published in high impact journals including Circulation, Blood, The Lancet, The New England Journal of Medicine, Thrombosis and Haemostasis, as well as several chapters in books. She is an active member of the World Federation of Hemophilia (WFH), the Israel Society of Pediatric Hematology and Oncology (ISPHO), and the American Society of Hematology (ASH). She is also an active reviewer for high impact thrombosis journals and an editorial board member of Haemophilia. She chairs the Israel Society of Thrombosis and Hemostasis, and has chaired the Perinatal and Paediatric Haemostasis Scientific Subcommittee of the International Society on Thrombosis and Haemostasis (ISTH).

 

AARON LUBETSKY, MD

Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

 

Aaron Lubetsky is an internist who trained at Sheba Medical Center in Tel Hashomer, Israel and is currently Director of the Coagulation and Thrombosis Unit. He received his medical degree from the Hebrew University in Jerusalem, Israel, where he also received his MSc in Clinical Epidemiology.

 

Dr Lubetsky's research projects are focused on adult haemostasis, adult thrombotic and coagulation disorders, anticoagulant therapy and thrombophilia, as well as clinical research in people with haemophilia.

 

Dr Lubetsky is the author of over 60 manuscripts, as well as several book chapters. He is an active member of the World Federation of Hemophilia (WFH), the Israel Society of Thrombosis and Hemostasis, and the American Society of Hematology (ASH). He has chaired the Israel Society of Thrombosis and Hemostasis and was a member of the Control of Anticoagulation Scientific Subcommittee of the International Society on Thrombosis and Haemostasis (ISTH).

 

NATASCHA MARQUARDT, MD

University Hospital Bonn, Bonn, Germany

 

Natascha Marquardt is the Senior Physician at the Institute for Experimental Haematology and Transfusion Medicine at the University Hospital Bonn in Germany. She joined the faculty in 2003, and has subsequently attained specialisations in both transfusion medicine and hemostaseology (in 2007 and 2008 respectively).

 

Dr Marquardt has been an investigator in multiple clinical trials in haemophilia. She has a special interest in co-morbidities in elderly haemophilia patients. She also has a special interest in ultrasonography of haemophilic joints, and acts as a trainer in the HEAD US European Ultrasound Preceptorship Program.

 

URI MARTINOWITZ, MD

Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

 

Uri Martinowitz is a retired director of the Israeli National Hemophilia Center and Institute of Thrombosis and Hemostasis at the Sheba Medical Center in Tel Hashomer, Israel. He has been President and Chair of the Israeli Hemophilia Association and an executive member of the World Federation of Hemophilia (WFH). He established the National Hemophilia Center in 1982 and developed it into an International Hemophilia Training Center with over 25 employees. He initiated WFH surgical training programmes and organised training courses and surgeries in developing countries including India, the Philippines and Thailand.

 

Professor Martinowitz has received many national and international awards for his contribution to the field of haemostasis and haemophilia, including the Chairman of the Knesset (Israeli Parliament) Award, the Exemplary Physicians' Award from the Israel Society of Law and Medicine, the Minister of Health Award for life achievements, and the US Army Award for innovative approaches towards improving haemorrhage control in trauma.

 

Professor Martinowitz has contributed to over 160 publications in the field of haemophilia, bleeding disorders, fibrin glues, haemostasis and haemorrhage control in trauma and surgery.

 

PHILIPPE DE MOERLOOSE, MD

Geneva University Hospital, Geneva, Switzerland

 

Philippe de Moerloose is Emeritus professor in the Department of Internal Medicine, Head of the Haemostasis Unit and the Adjunct Head for the Division of Angiology and Haemostasis at the University Hospital in Geneva, Switzerland. He holds specialist training degrees in internal medicine, angiology and haematology.

 

Professor de Moerloose serves in numerous official capacities at local, national and international levels; he is Past President of the European Association for Haemophilia and Allied Disorders (EAHAD), as well as being on the editorial/advisory board of a number of medical journals including the Journal of Thrombosis and Haemostasis, where he was an associate editor.

 

Professor de Moerloose is a recurrent recipient of national and international grants in the field of thrombosis and haemostasis (especially in fibrinogen disorders and antiphospholipid antibodies). He has authored/co-authored over 400 peer-reviewed publications, review articles and book chapters.

 

RAMIRO NÚÑEZ, MD, PhD

Virgen del Rocío University Hospital, Seville, Spain

 

Ramiro Núñez has been a member of the Haemophilia Unit at the Virgen del Rocío University Hospital since 2002. The unit is a reference centre for the Andalusian community in Spain, researching congenital haemorrhagic coagulopathies and other thrombopathies, as well as the genetic study of patients with haemophilia and carriers.

 

Dr Núñez completed his medical degree and specialised in haematology at Seville University. His research interests include the management of inherited bleeding disorders, radiosynoviorthesis and von Willebrand disease.

 

Dr Núñez is a member of the Spanish Association of Haematology and Haemotherapy, the Spanish Society of Thrombosis and Haemostasis (SETH), and is an active member of the national working group for the prevention and treatment of patients with haemophilia and inhibitors. He has participated in national and international congresses, submitting several abstracts on coagulation disorders, and has participated in many clinical trials (phase I-IV).

 

JOHANNES OLDENBURG, MD, PhD

University Hospital Bonn, Bonn, Germany

 

Johannes Oldenburg is a professor and Director of the Institute of Experimental Haematology and Transfusion Medicine at the University Hospital Bonn in Germany, where he is also Head of the Haemophilia Centre.

 

Professor Oldenburg's research interests include the clinical phenotype and molecular genetics of blood coagulation factors with an emphasis on haemophilia and vitamin K pathways, and he has published more than 300 articles in these fields. He also serves as a reviewer for many professional journals in the field of thrombosis and haemostasis including Blood, Journal of Thrombosis and Haemostasis and Haemophilia.

 

Professor Oldenburg is a member of the International Society on Thrombosis and Haemostasis (ISTH), the American Society of Hematology (ASH) and the World Federation of Hemophilia (WFH).

 

INGRID PABINGER-FASCHING, MD

Medical University of Vienna, Vienna, Austria

 

Ingrid Pabinger-Fasching is the Professor of Haemostaseology at the Clinical Division of Haematology and Haemostaseology at the Medical University of Vienna in Austria. She is also Director of the institution's Haemophilia Centre. She completed her medical training and specialisation in internal medicine, haematology and oncology at the Medical University of Vienna.

 

Professor Pabinger-Fasching's current research interests include; thrombosis risk factors, haemophilia treatment and acquired haemorrhagic diathesis, coagulation abnormalities in patients with oncologic and haemato-oncologic diseases, immune thrombocytopenia, and haemostaseologic problems in critically ill patients.

 

Professor Pabinger-Fasching has published over 370 papers in peer-reviewed journals including The New England Journal of Medicine, Nature, Blood and Journal of Thrombosis and Haemostasis. She is presently Chairman of the International Society on Thrombosis and Haemostasis (ISTH), and Chairman of the Austrian Haemophilia Society's Scientific Advisory Board.

 

ANNARITA TAGLIAFERRI, MD

University Hospital of Parma, Parma, Italy

 

Annarita Tagliaferri has taken many roles at the University Hospital of Parma in Italy. She is a clinical associate at the Thrombosis and Haemophilia Centre in the Department of Internal Medicine, a professor at the School of Clinical and Laboratory Haematology, and Director of the Haemophilia Unit for adult and paediatric patients and of the Regional Reference Centre for Inherited Bleeding Disorders for the Emilia-Romagna region in Italy.

 

Dr Tagliaferri received her medical degree from the University of Parma, and later continued to specialise in endocrinology and haematology. She has given lectures on the results of her studies on coagulation disorders in haemophilia and inherited bleeding disorders.

 

Dr Tagliaferri has taken part in Italian and international multicentre trials and has coordinated several national clinical studies in the treatment of haemophilia and its complications. She is Head of the following regional projects for Emilia-Romagna: 'Web Connections of the Haemophilia Centres', and 'Network of the Haemophilia Centres and Emergency Department for Managing Bleeding Emergencies in Patients with Inherited Bleeding Disorders'.

 

Dr Tagliaferri is a member of many associations including the Italian Association of Haemophilia Centres, the Italian Society for Haemostasis and Thrombosis, and is a member of the Advisory Committee for the Regional Health Authority of Emilia-Romagna in Italy, and is member of the Executive Committee for the Italian Association of Haemophilia Centres.

 

Dr Tagliaferri has authored/co-authored over 105 papers, published in scientific journals.

 

JERZY WINDYGA, MD, PhD

Institute of Haematology and Transfusion Medicine, Warsaw, Poland

 

Jerzy Windyga is Head of the Department of Disorders of Haemostasis and Internal Medicine at the Institute of Haematology and Transfusion Medicine in Warsaw, Poland. He is a member of the World Federation of Hemophilia (WFH) Board of Directors (2014-2018) and the Polish Society of Haematology and Transfusion Medicine Executive Board (2011-2015). He is Chair of the WFH Twinning Committee, and in 2013, was President of the 6^th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD).

 

Since 2003, Professor Windyga has been a member of the Medical Board of the Polish Haemophilia Society, where he advises on recommendations for haemophilia management. He has authored/co-authored over 200 papers, published in Polish and international medical journals. His current research is focused on the management of haemophilia and other inherited bleeding disorders, inherited thrombotic thrombocytopenic purpura, as well as the management of venous thromboembolism, with a focus on thrombophilia and rare venous thromboses.

 

IRENA ZUPAN, MD, PhD

University Medical Centre Ljubljana, Ljubljana, Slovenia

 

Irena Zupan is a haematology specialist and Head of the Outpatient Department and Day Care Hospital at the Department of Haematology, University Medical Centre Ljubljana (UMCL) in Slovenia. She completed her specialisation in internal medicine and haematology at the UMCL.

 

Dr Zupan's clinical activities are focussed on the treatment of anaemia, haemostatic disorders and malignant diseases of blood and the haematopoietic system. In recent years, she has continued to work in the field of haematology with a focus on haemostasis. She has published many articles in Science Citation Index journals and national journals, as well as abstracts in national and international publications. She is also the Principal Investigator in many clinical studies.

 

Since 1999, Dr Zupan has given regular lectures and tutorials in internal propaedeutics, internal medicine and clinical haematology for students of the Faculty of Medicine and Pharmacy at the University of Ljubljana in Slovenia.